Does cyclosporine inhibit in vivo hepatitis C virus replication? - A pilot study [1]

Transplant International

Volumn 20, Issue 9, 2007, Pages 808-810

  Wawrzynowicz Syczewska, Marta ^a   Herman, Ewelina ^a   Jurczyk, Krzysztof ^a   Karpińska, Ewa ^a   Laurans, Łukasz ^a   Lubikowski, Jerzy ^b   Boroń Kaczmarska, Anna ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Provincial Hospital   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LIVER ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

DRUG INHIBITION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME ACTIVITY; HEPATITIS C VIRUS; HUMAN; IN VIVO STUDY; LETTER; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PILOT STUDY; PRIORITY JOURNAL; VIREMIA; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION;

CYCLOSPORINE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE; LIVER TRANSPLANTATION; PILOT PROJECTS; VIRUS REPLICATION;

EID: 34547699715     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00508.x     Document Type: Letter

References (16)

1. Prieto M, Berenguer M, Rayon JM, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection after transplantation: relationship with rejection episodes. Hepatology 1999 29 : 250.
2. Taga SA, Washington MK, Terrault N, et al. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg 1998 4 : 304.
3. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression after liver transplantation: increase in recent years. J Hepatol 2000 32 : 673.
4. Berenguer M, Crippin J, Gish R, et al. A model to predict severe HCV-related disease following liver transplantation. Hepatology 2003 38 : 34.
5. Papatheodoridis GV, Davies S, Dhillon AP, et al. The role of different immunosuppression in the long-term histological outcomeof HCV reinfection after liver transplantation for HCV cirrhosis. Transplantation 2001 72 : 412.
6. Everson GT. Impact of immunosuppressive therapy on recurrence of hepatitis C. Liver Transpl 2002 8 (Suppl. 1 S19.
7. Nakagawa M, Sakamoto N, Enomoto N, et al. Specific inhibition of hepatitis C virus replication by cyclosporin A. Biochem Biophys Res Commun 2004 313 : 42.
8. Manière T, Ethier C, Raymond VA, et al. Cyclosporin reduces hepatitis C virus replication in the replicon model. J Hepatol 2004 40 (Suppl. S120.
9. Watashi K, Hijakata M, Hosaka M, et al. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes. Hepatology 2003 38 : 1282.
10. Inoue K, Yoshiba M. Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease. Transplant Proc 2005 37 : 1233.
11. Inoue K, Sekiyama K, Yamada M, et al. Combined interferon alpha2b and cyclosporine A in the treatment of chronic hepatitis C: controlled trial. J Gastroenterol 2003 38 : 567.
12. Martin P, Busuttil RW, Goldstein RM, et al. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial. Liver Transpl 2004 10 : 1258.
13. Levy G., Villamil F., Samuel D, et al. Results of LIS2T, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with Co monitoring in de novo liver transplantation. Transplantation 2004 77 : 1632.
14. Berenguer M, Aguilera V, Prieto M, et al. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients. Liver Transpl 2006 12 : 762.
15. Levy G, Grazi GL, Sanjuan F, et al. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (c2 monitoring) and tacrolimus. Liver Transpl 2006 12 : 1464.
16. Lorho R, Turlin B, de Lajarte-Thirouard AS, et al. Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine. Transplant Proc 2005 37 : 2871.